CAMELYON16
A public pathology dataset for detecting lymph node metastases in breast cancer, commonly used as a benchmark for whole-slide image analysis tasks.
Timeline (last 90 days)
The study evaluated CLEAR-WSI on a comprehensive benchmark comprising two public datasets (CAMELYON16, BRACS) and one private clinical dataset (X-HER2), covering four retrieval tasks.
Compared with the strongest baseline, CLEAR-WSI improves Precision@5 across the board: CAMELYON16 by 3.10, BRACS-1 by 2.75, BRACS-2 by 1.95, and X-HER2 by 3.75.
All Facts (2)
The study evaluated CLEAR-WSI on a comprehensive benchmark comprising two public datasets (CAMELYON16, BRACS) and one private clinical dataset (X-HER2), covering four retrieval tasks.
50%UnverifiedCompared with the strongest baseline, CLEAR-WSI improves Precision@5 across the board: CAMELYON16 by 3.10, BRACS-1 by 2.75, BRACS-2 by 1.95, and X-HER2 by 3.75.
50%